Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.12.2024MEDOCHEMIE Ltd. (MOE)46243MEDOTRIGIN 100 mg (tbl 30x100 mg)16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)46245MEDOTRIGIN 100 mg (tbl 100x100 mg)16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)4778BAKTIPROL 200 mg tablety (tbl 60x200 mg (blis.PVC/PVDC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)4784BAKTIPROL 400 mg tablety (tbl 60x400 mg (blis.PVC/PVDC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)5231BAXETINE 250 mg (tbl flm 10x250 mg (blis.Al/Al))16.12.2024R
 20.12.2024MEDOCHEMIE Ltd. (MOE)54423MAGRILAN 20 mg (cps dur 30x20 mg (blis.PVC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)67030MEDOFLUCON 50 mg (cps dur 7x50 mg (blis.PVC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)67512MEDOCRIPTINE (tbl 30x2,5 mg (blis.PVC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)7675BSAGILIA 1mg tablety (tbl 100x1 mg (blis.PVC/PE/PVDC/Al))16.12.2024O
 20.12.2024MEDOCHEMIE Ltd. (MOE)96084MEDOFLUCON 150 mg (cps dur 1x150 mg (blis.PVC/Al))16.12.2024O
 19.12.2024B.Braun Melsungen AG (BME)34254Glukóza B. Braun 5 % infúzny roztok (sol inf 10x500 ml (fľ.LDPE))19.12.2024R
 19.12.2024B.Braun Melsungen AG (BME)2917AKaliumchlorid/natriumchlorid 0,3 % + 0,9 % B. Braun (sol inf 10x500 ml (fľ.PE))19.12.2024R
 19.12.2024B.Braun Melsungen AG (BME)5009BAqua pro injectione Braun (lif par 10x1000 ml (fľ.LDPE))19.12.2024R
 19.12.2024Egis Pharmaceuticals PLC (EGI)7182EKrufton 150 mg tvrdé kapsuly (cps dur 112 (4x28)x150 mg (blis.PVC/PE/PVDC//Al))19.12.2024U
 19.12.2024Egis Pharmaceuticals PLC (EGI)7184EKrufton 200 mg tvrdé kapsuly (cps dur 112 (4x28)x200 mg (blis.PVC/PE/PVDC//Al))19.12.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)